Blog
RSS FeedPosted by Michael Wonder on 23 Oct 2017
Health care underfunded for too long
23 October 2017 - The death of an elderly man - who broke his hip and died after surgery was ...
Posted by Michael Wonder on 23 Oct 2017
NICE bars NHS access to Lenvima, Nexavar for thyroid cancer
23 October 2017 - NHS treatment cost regulators have published draft guidelines rejecting funding for Eisai’s Lenvima and Bayer’s Nexavar ...
Posted by Michael Wonder on 23 Oct 2017
GSK wins U.S. shingles vaccine approval, UK nod for gene therapy
23 October 2017 - GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three ...
Posted by Michael Wonder on 23 Oct 2017
NICE approves gene therapy for rare ‘bubble baby syndrome’
23 October 2017 - Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’ ...
Posted by Michael Wonder on 23 Oct 2017
NHS to fund gene therapy for 'bubble babies'
23 October 2017 - The NHS will fund gene therapy for the first time, with a £500,000 treatment for “bubble ...
Posted by Michael Wonder on 23 Oct 2017
Taxpayer-funded drugs 'too expensive for patients’
22 October 2017 - Taxpayer-funded medical research is producing medicines which are increasingly unaffordable for patients who need them, says ...
Posted by Michael Wonder on 21 Oct 2017
Agenda for 25 October TC meeting
20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 20 Oct 2017
National PreP service would be cost effective, research finds
20 October 2017 - Providing pre-exposure prophylaxis treatment to men who have sex with men at high risk of contracting ...
Posted by Michael Wonder on 20 Oct 2017
NICE no for Opdivo in urothelial carcinoma
20 October 2017 - The National Institute for Health and Care Excellence has published draft guidelines rejecting NHS funding for ...
Posted by Michael Wonder on 18 Oct 2017
Economic evaluation of personalised medicine: a call for real-world data
18 October 2017 - In the last decade, we have witnessed a change in healthcare management, with ‘personalised medicine’ as the ...
Posted by Michael Wonder on 17 Oct 2017
‘No-deal’ Brexit could cost NHS £500m a year
17 October 2017 - A ‘no-deal’ Brexit that ends healthcare arrangements between the UK and the EU could end up ...
Posted by Michael Wonder on 17 Oct 2017
'We took a shot and it worked': Immunotherapy delivering results for cancer sufferers
16 October 2017 - Twenty-six-year-old Sydney engineering student Igor Mileusnic is a strapping picture of health. Two years ago he ...
Posted by Michael Wonder on 16 Oct 2017
Health insurance still expensive despite reforms: analysts
17 October 2017 - The federal government’s list of private health insurance reforms, lauded as the most significant in almost ...
Posted by Michael Wonder on 16 Oct 2017
Roche’s skin cancer drug Erivedge pulled from CDF
13 October 2017 - Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute ...
Posted by Michael Wonder on 16 Oct 2017
Social value and individual choice: the value of a choice-based decision-making process in a collectively funded health system
4 October 2017 - Evidence about cost-effectiveness is increasingly being used to inform decisions about the funding of new technologies that ...